HUM-MOLGEN events: BioArrays-2003-New York Meeting: “Biochips in Diagnostics, Industrial Genomics & Proteomics: SystemomicsTM Approaches”

HUM-MOLGEN -> Events -> Meetings and Conferences

BioArrays-2003-New York Meeting: “Biochips in Diagnostics, Industrial Genomics & Proteomics: SystemomicsTM Approaches”

July 29, 2003

GeneExpresssion Systems, Inc., At Holiday Inn Midtown, 440 West 57th Street, New York City, New York, USA
October 1-2, 2003

20 leading researchers from the academic, biotech and pharmaceutical Communities will be speaking on the Biochips Applications in Molecular Diagnostics, Drug Target Validation using Industrial level of high throughput Genomics and Proteomics Strategies.
“Unique Theme to Combine Diagnostics and Industrial Omics”

Target audience:
Executives, Directors and Scientists of R&D from biotech and pharmaceuticals.
Graduate students, Post-docs, and Professors from Academia.
Investors, Thought leaders and Business Development people in life sciences who need to know the emerging technologies in the
“Systemomics TM and Molecular Diagnostics arenas.

Highlights of the Meeting:
· Global Gene and Protein profiling in various diseases
· Biomarkers and surrogate marker(s) discovery
· Tumor and Pathway Classifications, Bioinformatics Data mining
· Disease Diagnosis, Prognosis and Prevention strategies
· Diagnostic Arrays, Toxicity screenings and Predictive Toxicology
· Microfluidics chip and Array tube Technologies
· Technology Workshops, Panel Discussion with the Experts

Organized by:

Krishnarao Appasani, PhD.

Invited Speakers:

List of Speakers Include:
- Dr. Thomas J. Vasicek, PhD. Vice President of Business Development, Lynx Therapeutics, Inc.
Hayward, California
- Dr. Jeffrey S. Ross, M.D. Vice President Molecular Medicine, Millennium Pharmaceuticals, Inc.
Cambridge, MA, and Chairman of the Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY
- Dr. Steven R. Gullans, PhD. Chief Scientific Office, U.S. Genomics, Inc. Woburn, MA and Associate
Professor, Harvard Medical School, Boston, MA
- Dr. Stephen D. Nimer, Head of Hematological Oncology, Memorial Sloan-Kettering Cancer Center,
New York, NY
- Dr. Jeffrey Waring, PhD. Associate Research Investigator, Abbott Laboratories, Abbott Park, IL
- Dr. Robert Dullea, PhD. Cancer Profiling Group, Pfizer R&D, Groton, CT
- Dr. Paul Predki, PhD. Vice President, Research & Development, Protometrix, Inc. Branford, CT
- Dr. Sam Hanash, Professor of Pediatrics, University of Michigan, Ann Arbor, MI
- Dr. William Gerald, MD. Memorial Sloan Kettering Cancer Center, New York, NY
- Dr. Eric M. Eastman, Ph.D. Chief Scientific Officer, MetriGenix, Inc. Gaithersburg, MD
- Dr. Michael Mallamaci, Ph.D. AstraZeneca Pharmaceuticals, Wilmington, DE
- Dr. Towia A. Libermann, PhD. Associate Professor, Harvard Medical School, Boston, MA
- Dr. J. L. Walewski, PhD. Assistant Professor, Mount Sinai School of Medicine, New York, NY
- Dr. Jeff Brockman, PhD. Senior Scientist, Psychiatric Genomics, Inc. Gaithersburg, MD
- Dr. Monica Mody, PhD. Senior Applications Specialist, Affymetrix, Inc. Santa Clara, CA
- Dr. David Munroe, PhD. National Cancer Institute, FCRF, Frederick, MD
- Dr. Ghil Jona, PhD. (Prof. Michael Snyder’s Lab), Yale University, New Haven, CT
- Dr. Timothy D. Veenstra, PhD. Director, Biomedical Proteomics Program, National Cancer Institute,
Frederick, MD
-Dr. John Tonkinson, PhD. Marketing Manager, Schleicher & Schuell Bioscience, Inc. Keene, NH

and many more.....

Technology Work shop Sponsors:
Schleicher & Schuell Bioscience, Inc. Keene, NH
Amersham Bioscience, Piscataway, NJ

Deadline for Abstracts:

Sept. 10, 2003

Registration:

Academia/Govt: $699 Industry : $1,099

E-mail:

Genexpsys@expressgenes.com

Posted by:

Krishnarao Appasani

Host:

h00a0249a09cd.ne.client2.attbi.com